Artificial Intelligence

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

An independent board again backs the safety of BriaCell's metastatic breast cancer therapy in a pivotal Phase 3 trial, boosting hope for a new treatment.

Israeli tech firm Nanox will debut its low-cost Nanox.ARC imaging system in Europe, pairing it with AI that spots chronic disease in routine scans.

Continu launches 'Experts,' an AI tool that securely connects to Google Drive and OneDrive, delivering instant, permission-aware answers in Slack and Teams.

A new supply agreement for the rare isotope Actinium-225 between NorthStar and BIOEMTECH promises to break a critical bottleneck in radiopharmaceutical R&D.

New research reveals a startling link between AI's excessive permissions and a surge in security breaches, forcing a rethink of enterprise trust and access.

As AI creates data bottlenecks, Lumen launches a new Multi-Cloud Gateway and metro network expansion, aiming to simplify hybrid IT and power innovation.

New research reveals a startling mobile security gap, with 72% of firms facing incidents and 65% losing customers as AI and speed pressures add new risks.

With a bolstered balance sheet and a sharpened focus, Palatin Technologies is advancing two novel obesity drugs into clinical trials for rare genetic disorders.

A new series from A3 and BBC StoryWorks moves beyond efficiency to show how automation is augmenting human lives in healthcare, education, and more.

SaaS veteran Alison Forsythe takes the helm at Intellinetics, tasked with turning heavy investment into profitable growth in the booming digital transformation market.

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.

Fresh off its IPO, Lumexa Imaging's leadership heads to key conferences. Here’s what’s at stake as they pitch their growth strategy to investors.

A new FDA approval allows a lung cancer therapy to be given just once a month, a major shift promising to reduce clinic time and improve quality of life.

Vexcel announces its 2026 plan to capture 5.2M km² of U.S. aerial imagery, powering critical industries from insurance to AI with unprecedented detail.

A new program in Michigan uses AI to analyze existing CT scans, detecting silent heart risks and connecting patients to care before symptoms even appear.

A new five-year deal will leverage patient-derived stem cells and AI to revolutionize the hunt for Alzheimer's cures, aiming to bridge a critical gap.

A new partnership aims to manufacture a life-saving gene therapy for NKH, a devastating rare disorder, driven by a family's relentless advocacy.

New research reveals a swift move to AI in accounting, but professionals insist on one condition: technology will assist, not replace, human oversight.

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.